TherapeuticsMD Balance Sheet (2010-2026) | TXMD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	111.42M	104.84M	64.91M	30.38M	26.30M	38.33M	49.32M	17.25M	13.73M	10.17M	4.33M	4.34M	5.23M	5.05M	5.06M	5.75M	6.07M	7.12M	7.48M	8.42M
Short-term Investments (Quarter)					11.25M	11.25M	11.25M
Cash & Current Investments (Quarter)	111.42M	104.84M	64.91M	30.38M	37.55M	49.58M	60.57M	17.25M	13.73M	10.17M	4.33M	4.34M	5.23M	5.05M	5.06M	5.75M	6.07M	7.12M	7.48M	8.42M
Receivables - Net (Quarter)	33.48M	37.40M	36.18M	35.41M	45.80M	32.16M
Receivables - Other (Quarter)											21.57M	3.22M	2.91M	3.32M	3.56M	3.00M	3.74M	3.67M	3.52M	3.21M
Receivables (Quarter)	33.48M	37.40M	36.18M	35.41M	45.80M	32.16M
Raw Materials (Quarter)	4.53M	3.49M	3.04M	4.39M	0.43M	1.95M
Work In Process (Quarter)	0.74M	0.69M	1.64M	1.23M	1.68M	0.22M
Finished Goods (Quarter)	2.30M	3.19M	2.94M	3.34M	4.03M	4.54M
Inventory (Quarter)	7.57M	7.36M	7.62M	8.97M	6.15M	6.70M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	7.18M	3.80M	2.73M	1.64M	0.56M	2.37M	1.17M	5.45M	5.04M	4.57M	1.45M	0.23M	1.18M	3.78M	0.69M	0.23M	3.65M	3.72M	0.09M	0.41M
Current Assets (Quarter)	159.66M	159.98M	119.47M	84.42M	98.60M	87.48M	55.35M	24.73M	19.61M	17.44M	11.80M	11.52M	11.82M	12.15M	12.26M	12.51M	13.46M	14.50M	14.45M	15.26M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.65M	1.39M	0.82M	1.08M	0.71M	0.55M	0.08M	0.06M	0.04M	0.02M
Intangibles (Quarter)	46.42M	39.62M	7.14M	39.55M	48.42M	48.45M	6.94M	6.88M	6.77M	6.66M	6.10M	5.96M	6.39M	4.43M	6.38M	4.14M	6.29M	3.91M	6.18M	6.18M
Goodwill & Intangibles (Quarter)	46.42M	39.62M	7.14M	39.55M	48.42M	48.45M	6.94M	6.88M	6.77M	6.66M	6.10M	5.96M	6.39M	4.43M	6.38M	4.14M	6.29M	3.91M	6.18M	6.18M
Other Non-Current Assets (Quarter)	0.25M	0.25M	48.70M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.06M	0.09M	0.06M	0.06M	0.13M	0.21M	0.43M	0.47M	0.44M	0.42M
Non-Current Assets (Quarter)	50.94M	49.65M	50.00M	48.96M	47.60M	46.43M	35.11M	34.87M	34.08M	33.05M	31.51M	30.57M	28.30M	27.40M	26.56M	25.72M	25.04M	24.17M	23.21M	22.32M
Assets (Quarter)	210.60M	209.63M	169.47M	133.38M	146.20M	133.91M	90.46M	59.60M	53.69M	50.49M	43.31M	42.09M	40.13M	39.55M	38.82M	38.24M	38.50M	38.67M	37.66M	37.58M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	14.56M	19.59M	3.37M	20.75M	13.98M	13.38M	2.16M	2.33M	1.51M	0.70M	0.03M	0.14M	0.14M	2.82M	0.26M	0.18M	1.59M	2.02M	0.38M	0.01M
Notes Payables (Quarter)
Dividends payables (Quarter)
Payables (Quarter)	14.56M	19.59M	3.37M	20.75M	13.98M	13.38M	2.16M	2.33M	1.51M	0.70M	0.03M	0.14M	0.14M	2.82M	0.26M	0.18M	1.59M	2.02M	0.38M	0.01M
Accumulated Expenses (Quarter)	7.37M	6.22M	44.30M								3.13M				2.13M	0.13M	1.59M	2.02M	1.74M	2.23M
Other Accumulated Expenses (Quarter)			13.34M	41.23M	59.23M	43.57M	18.85M	14.36M	11.48M	6.93M	0.41M				0.09M	0.25M	0.20M	0.30M
Short term Debt (Quarter)	10.00M	15.00M	188.27M	202.86M	90.78M	93.60M
Current Leases (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	75.67M	86.27M	252.89M	264.83M	163.99M	174.07M	46.84M	19.34M	14.36M	14.51M	6.85M	6.47M	5.82M	5.98M	5.17M	4.74M	4.66M	4.95M	4.79M	4.91M
Non-Current Liabilities
Non-Current Debt (Quarter)	175.26M	171.74M
Liabilities from Discontinued Operations (Quarter)			47.91M				25.83M	2.65M	1.37M	6.89M	3.69M	6.32M	3.00M	2.92M	2.78M	2.79M	2.72M	2.67M	2.67M	2.67M
Operating Leases (Quarter)	8.38M	8.23M	8.06M	7.90M	7.73M	7.55M	7.37M	7.13M	6.94M	6.74M	6.53M			5.78M	7.17M	5.96M	5.72M	5.41M	5.12M	4.82M
Other Non-Current Liabilities (Quarter)	0.36M	0.76M	2.14M	1.23M	0.55M	0.55M	1.11M	1.11M	1.19M	1.19M	0.64M	0.64M	0.64M	0.70M	0.74M	0.80M	0.83M	0.87M	0.87M	0.87M
Total Non-Current Liabilities (Quarter)	259.32M	266.23M	260.95M	272.73M	171.71M	181.62M	54.21M	26.47M	21.30M	21.25M	13.39M	12.79M	11.82M	11.75M	10.71M	10.70M	10.38M	10.36M	9.91M	9.73M
Total Liabilities (Quarter)	259.68M	266.99M	263.09M	273.96M	172.27M	182.18M	55.31M	27.58M	22.49M	22.44M	14.02M	13.42M	12.46M	12.46M	11.45M	11.50M	11.21M	11.23M	10.78M	10.61M
Shareholder's Equity
Total Debt (Quarter)	185.26M	186.74M	188.27M	202.86M	90.78M	93.60M
Common Equity (Quarter)	-49.07M	-57.36M	-93.62M	-140.58M	-26.07M	-48.27M	35.14M	32.02M	31.20M	28.05M	29.29M	28.66M	27.67M	27.09M	27.37M	26.74M	27.29M	27.44M	26.88M	26.97M
Shareholder's Equity (Quarter)	-49.07M	-57.36M	-93.62M	-140.58M	-26.07M	-48.27M	35.14M	32.02M	31.20M	28.05M	29.29M	28.66M	27.67M	27.09M	27.37M	26.74M	27.29M	27.44M	26.88M	26.97M
Liabilities and Shareholders Equity (Quarter)	210.60M	209.63M	169.47M	133.38M	146.20M	133.91M	90.46M	59.60M	53.69M	50.49M	43.31M	42.09M	40.13M	39.55M	38.82M	38.24M	38.50M	38.67M	37.66M	37.58M
Retained Earnings (Quarter)	-960.98M	-1008.40M	-1051.36M	-1100.38M	-988.10M	-1017.07M	-939.36M	-942.97M	-945.38M	-948.76M	-949.64M	-950.38M	-951.47M	-952.07M	-951.82M	-952.48M	-951.92M	-951.77M	-952.39M	-952.30M
Treasury Shares (Quarter)	2.38M	1.68M	164.00	0.01M	0.15M	0.10M	0.02M	0.18M	0.01M	0.08M	0.04M	38.00	0.01M	0.01M	0.03M	0.01M			0.03M	0.03M

Research Tools

TherapeuticsMD Balance Sheet (2010-2026) | TXMD

Create an account

Sign In

Reset Password